FIGURE
Figure 5
- ID
- ZDB-FIG-210902-112
- Publication
- Feng et al., 2021 - FDA-Approved Drug Screening for Compounds That Facilitate Hematopoietic Stem and Progenitor Cells (HSPCs) Expansion in Zebrafish
- Other Figures
- All Figure Page
- Back to All Figure Page
Figure 5
Comparison of the analog effects of ergocalciferol and panthenol. (A) WISH of cmyb after treating with ergocalciferol and its analogs (cholecalciferol and calcifediol) as well as panthenol and its analog (D-pantothenic acid). Blue arrowheads indicate cmyb+ signals. (B) Statistical data of (A) (Pixels; DMSO, 16,090 ± 659; Ergocalciferol, 29,110 ± 1399; Cholecalciferol, 15,840 ± 821; Calcifediol, 15,880 ± 485; Panthenol, 29,340 ± 1014; D-pantothenic acid, 16,790 ± 689). Scale bar, 50 μm; Mean ± SEM, n = 8; ns, no significance; **** p < 0.0001. |
Expression Data
Expression Detail
Antibody Labeling
Phenotype Data
Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Cells